Status:
COMPLETED
Impact of Erector Spinae Plane Block on Systemic Immune-inflammation Index
Lead Sponsor:
Taner Abdullah
Conditions:
Systemic Immune-inflammatory Index
Erector Spinae Plane Block
Eligibility:
FEMALE
18+ years
Brief Summary
The primary objective of the study is to determine whether there is a relationship between postoperative SII and erector spinae plane block application. If data emerges indicating a more suppressed in...
Detailed Description
Because the study will be conducted retrospectively, it carries no potential risks. If it can be demonstrated that blocking has a suppressive effect on the inflammatory response, the main expected be...
Eligibility Criteria
Inclusion
- ASA score ≤ 3, breast-conversing surgery, age \> 18 -
Exclusion
- ASA score \> 3, reoperation, surgical wound infection, chemotherapy in less than 2 weeks, bening lesions
- \-
Key Trial Info
Start Date :
July 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 15 2025
Estimated Enrollment :
127 Patients enrolled
Trial Details
Trial ID
NCT07137702
Start Date
July 15 2025
End Date
August 15 2025
Last Update
August 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Basaksehir Cam ve Sakura City Hospital
Istanbul, Turkey (Türkiye)